Company Name : Cairo Pharmaceuticals ISIN Code : EGS38391C016 Currency : EGP F/S Period : From 01/07/2025 To 31/12/2025 Net Profit : 268,960,959 F/S Period: From 01/07/2024 To 31/12/2024 Net Comparative Profit : 245,789,794 Audit Status : Reviewed Source : Cairo Pharmaceuticals